PDB Short entry for 2PVV HEADER HYDROLASE 10-MAY-07 2PVV TITLE STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX TITLE 2 WITH L-SERINE-O-SULFATE CAVEAT 2PVV MAN E 3 HAS WRONG CHIRALITY AT ATOM C1 OSE A 1768 HAS WRONG CAVEAT 2 2PVV CHIRALITY AT ATOM CA COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE CARBOXYPEPTIDASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 5 SYNONYM: GLUTAMATE CARBOXYPEPTIDASE II, MEMBRANE GLUTAMATE COMPND 6 CARBOXYPEPTIDASE, MGCP, N-ACETYLATED-ALPHA-LINKED ACIDIC DIPEPTIDASE COMPND 7 I, NAALADASE I, PTEROYLPOLY-GAMMA-GLUTAMATE CARBOXYPEPTIDASE, COMPND 8 FOLYLPOLY-GAMMA- GLUTAMATE CARBOXYPEPTIDASE, FGCP, FOLATE HYDROLASE COMPND 9 1, PROSTATE- SPECIFIC MEMBRANE ANTIGEN, PSMA, PSM; COMPND 10 EC: 3.4.17.21; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FOLH1, FOLH, NAALAD1, PSM, PSMA; SOURCE 6 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SCHNEIDER'S S2 CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PMT/BIP/V5-HIS A KEYWDS PROSTATE SPECIFIC MEMBRANE ANTIGEN; METALLOPEPTIDASE; FOLATE KEYWDS 2 HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; NAALADASE; L-SERINE-O- KEYWDS 3 SULFATE; L-SOS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.BARINKA,J.LUBKOWSKI REVDAT 6 30-AUG-23 2PVV 1 HETSYN REVDAT 5 29-JUL-20 2PVV 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HETNAM LINK SITE ATOM REVDAT 4 13-JUL-11 2PVV 1 VERSN REVDAT 3 24-FEB-09 2PVV 1 VERSN REVDAT 2 14-AUG-07 2PVV 1 JRNL REVDAT 1 22-MAY-07 2PVV 0 JRNL AUTH C.BARINKA,M.ROVENSKA,P.MLCOCHOVA,K.HLOUCHOVA,A.PLECHANOVOVA, JRNL AUTH 2 P.MAJER,T.TSUKAMOTO,B.S.SLUSHER,J.KONVALINKA,J.LUBKOWSKI JRNL TITL STRUCTURAL INSIGHT INTO THE PHARMACOPHORE POCKET OF HUMAN JRNL TITL 2 GLUTAMATE CARBOXYPEPTIDASE II. JRNL REF J.MED.CHEM. V. 50 3267 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17567119 JRNL DOI 10.1021/JM070133W REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 57236 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3061 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.11 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3972 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.61 REMARK 3 BIN R VALUE (WORKING SET) : 0.2030 REMARK 3 BIN FREE R VALUE SET COUNT : 217 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5529 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 191 REMARK 3 SOLVENT ATOMS : 510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.47000 REMARK 3 B22 (A**2) : -2.21000 REMARK 3 B33 (A**2) : 0.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.167 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.152 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.101 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.659 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5985 ; 0.021 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8132 ; 1.803 ; 1.992 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 699 ; 6.431 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 278 ;38.892 ;23.777 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 953 ;14.712 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;16.406 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 879 ; 0.125 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4548 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2930 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4088 ; 0.316 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 568 ; 0.167 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 7 ; 0.105 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 93 ; 0.242 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 32 ; 0.161 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3627 ; 1.127 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5672 ; 1.769 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2724 ; 2.808 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2460 ; 4.060 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2PVV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042830. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60304 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.50500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2OOT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% (V/V) PENTAERYTHRITOL PROPOXYLATE REMARK 280 PO/OH 5/4, 1 3% (W/V) PEG 3350, 100 MM TRIS-HCL, PH 8.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 50.80850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.11000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 79.48750 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 50.80850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.11000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 79.48750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 50.80850 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 65.11000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 79.48750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 50.80850 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 65.11000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 79.48750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL ASSEMBLY IS A DIMER. REMARK 300 THERE IS ONE MOLECULE OF GCPII IN AN ASYMETRIC UNIT. REMARK 300 THE BIOLOGICAL DIMER IS FORMED USING "-X; 1-Y; Z" SYMMETRY OPERATOR. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -146.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 130.22000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1807 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 42 REMARK 465 SER A 43 REMARK 465 LYS A 44 REMARK 465 SER A 45 REMARK 465 SER A 46 REMARK 465 ASN A 47 REMARK 465 GLU A 48 REMARK 465 ALA A 49 REMARK 465 THR A 50 REMARK 465 ASN A 51 REMARK 465 ILE A 52 REMARK 465 THR A 53 REMARK 465 PRO A 54 REMARK 465 ASP A 654 REMARK 465 LYS A 655 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 242 O HOH A 2242 2.02 REMARK 500 O HOH A 2057 O HOH A 2138 2.06 REMARK 500 NE2 GLN A 620 O HOH A 2116 2.10 REMARK 500 OE2 GLU A 152 O HOH A 1982 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 102 CG GLU A 102 CD 0.097 REMARK 500 VAL A 158 CB VAL A 158 CG1 0.127 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 152 2.94 -68.98 REMARK 500 PHE A 164 -1.87 88.36 REMARK 500 ASN A 178 -132.70 57.51 REMARK 500 LYS A 207 -52.60 78.92 REMARK 500 ASN A 260 76.79 -119.94 REMARK 500 ASP A 316 -177.53 -172.72 REMARK 500 GLU A 367 72.50 -118.46 REMARK 500 VAL A 382 -104.03 -128.83 REMARK 500 ALA A 452 54.91 -159.25 REMARK 500 SER A 454 118.97 -35.68 REMARK 500 PHE A 488 25.54 -141.05 REMARK 500 SER A 517 -154.76 -137.67 REMARK 500 TRP A 541 79.26 -26.89 REMARK 500 GLU A 542 -75.95 -35.80 REMARK 500 ASN A 544 30.59 -90.57 REMARK 500 ASP A 567 62.77 -156.78 REMARK 500 ASP A 683 15.09 52.23 REMARK 500 ASN A 698 94.28 -168.87 REMARK 500 PHE A 705 59.29 35.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1753 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 269 O REMARK 620 2 THR A 269 OG1 70.1 REMARK 620 3 TYR A 272 O 74.6 89.9 REMARK 620 4 GLU A 433 OE1 148.6 88.5 83.0 REMARK 620 5 GLU A 433 OE2 150.5 99.9 134.3 53.2 REMARK 620 6 GLU A 436 OE2 105.4 170.0 80.2 91.8 88.3 REMARK 620 7 HOH A1774 O 74.5 93.5 145.6 131.3 78.7 93.7 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1752 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 377 NE2 REMARK 620 2 ASP A 387 OD1 104.0 REMARK 620 3 ASP A 453 OD2 101.7 125.4 REMARK 620 4 ASP A 453 OD1 81.3 85.6 52.1 REMARK 620 5 HOH A2263 O 109.1 108.2 107.5 159.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1751 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 387 OD2 REMARK 620 2 GLU A 425 OE1 159.2 REMARK 620 3 GLU A 425 OE2 104.8 57.5 REMARK 620 4 HIS A 553 NE2 89.7 86.4 108.2 REMARK 620 5 HOH A2263 O 99.8 93.5 96.0 150.8 REMARK 620 N 1 2 3 4 DBREF 2PVV A 44 750 UNP Q04609 FOLH1_HUMAN 44 750 SEQADV 2PVV ARG A 42 UNP Q04609 CLONING ARTIFACT SEQADV 2PVV SER A 43 UNP Q04609 CLONING ARTIFACT SEQRES 1 A 709 ARG SER LYS SER SER ASN GLU ALA THR ASN ILE THR PRO SEQRES 2 A 709 LYS HIS ASN MET LYS ALA PHE LEU ASP GLU LEU LYS ALA SEQRES 3 A 709 GLU ASN ILE LYS LYS PHE LEU TYR ASN PHE THR GLN ILE SEQRES 4 A 709 PRO HIS LEU ALA GLY THR GLU GLN ASN PHE GLN LEU ALA SEQRES 5 A 709 LYS GLN ILE GLN SER GLN TRP LYS GLU PHE GLY LEU ASP SEQRES 6 A 709 SER VAL GLU LEU ALA HIS TYR ASP VAL LEU LEU SER TYR SEQRES 7 A 709 PRO ASN LYS THR HIS PRO ASN TYR ILE SER ILE ILE ASN SEQRES 8 A 709 GLU ASP GLY ASN GLU ILE PHE ASN THR SER LEU PHE GLU SEQRES 9 A 709 PRO PRO PRO PRO GLY TYR GLU ASN VAL SER ASP ILE VAL SEQRES 10 A 709 PRO PRO PHE SER ALA PHE SER PRO GLN GLY MET PRO GLU SEQRES 11 A 709 GLY ASP LEU VAL TYR VAL ASN TYR ALA ARG THR GLU ASP SEQRES 12 A 709 PHE PHE LYS LEU GLU ARG ASP MET LYS ILE ASN CYS SER SEQRES 13 A 709 GLY LYS ILE VAL ILE ALA ARG TYR GLY LYS VAL PHE ARG SEQRES 14 A 709 GLY ASN LYS VAL LYS ASN ALA GLN LEU ALA GLY ALA LYS SEQRES 15 A 709 GLY VAL ILE LEU TYR SER ASP PRO ALA ASP TYR PHE ALA SEQRES 16 A 709 PRO GLY VAL LYS SER TYR PRO ASP GLY TRP ASN LEU PRO SEQRES 17 A 709 GLY GLY GLY VAL GLN ARG GLY ASN ILE LEU ASN LEU ASN SEQRES 18 A 709 GLY ALA GLY ASP PRO LEU THR PRO GLY TYR PRO ALA ASN SEQRES 19 A 709 GLU TYR ALA TYR ARG ARG GLY ILE ALA GLU ALA VAL GLY SEQRES 20 A 709 LEU PRO SER ILE PRO VAL HIS PRO ILE GLY TYR TYR ASP SEQRES 21 A 709 ALA GLN LYS LEU LEU GLU LYS MET GLY GLY SER ALA PRO SEQRES 22 A 709 PRO ASP SER SER TRP ARG GLY SER LEU LYS VAL PRO TYR SEQRES 23 A 709 ASN VAL GLY PRO GLY PHE THR GLY ASN PHE SER THR GLN SEQRES 24 A 709 LYS VAL LYS MET HIS ILE HIS SER THR ASN GLU VAL THR SEQRES 25 A 709 ARG ILE TYR ASN VAL ILE GLY THR LEU ARG GLY ALA VAL SEQRES 26 A 709 GLU PRO ASP ARG TYR VAL ILE LEU GLY GLY HIS ARG ASP SEQRES 27 A 709 SER TRP VAL PHE GLY GLY ILE ASP PRO GLN SER GLY ALA SEQRES 28 A 709 ALA VAL VAL HIS GLU ILE VAL ARG SER PHE GLY THR LEU SEQRES 29 A 709 LYS LYS GLU GLY TRP ARG PRO ARG ARG THR ILE LEU PHE SEQRES 30 A 709 ALA SER TRP ASP ALA GLU GLU PHE GLY LEU LEU GLY SER SEQRES 31 A 709 THR GLU TRP ALA GLU GLU ASN SER ARG LEU LEU GLN GLU SEQRES 32 A 709 ARG GLY VAL ALA TYR ILE ASN ALA ASP SER SER ILE GLU SEQRES 33 A 709 GLY ASN TYR THR LEU ARG VAL ASP CYS THR PRO LEU MET SEQRES 34 A 709 TYR SER LEU VAL HIS ASN LEU THR LYS GLU LEU LYS SER SEQRES 35 A 709 PRO ASP GLU GLY PHE GLU GLY LYS SER LEU TYR GLU SER SEQRES 36 A 709 TRP THR LYS LYS SER PRO SER PRO GLU PHE SER GLY MET SEQRES 37 A 709 PRO ARG ILE SER LYS LEU GLY SER GLY ASN ASP PHE GLU SEQRES 38 A 709 VAL PHE PHE GLN ARG LEU GLY ILE ALA SER GLY ARG ALA SEQRES 39 A 709 ARG TYR THR LYS ASN TRP GLU THR ASN LYS PHE SER GLY SEQRES 40 A 709 TYR PRO LEU TYR HIS SER VAL TYR GLU THR TYR GLU LEU SEQRES 41 A 709 VAL GLU LYS PHE TYR ASP PRO MET PHE LYS TYR HIS LEU SEQRES 42 A 709 THR VAL ALA GLN VAL ARG GLY GLY MET VAL PHE GLU LEU SEQRES 43 A 709 ALA ASN SER ILE VAL LEU PRO PHE ASP CYS ARG ASP TYR SEQRES 44 A 709 ALA VAL VAL LEU ARG LYS TYR ALA ASP LYS ILE TYR SER SEQRES 45 A 709 ILE SER MET LYS HIS PRO GLN GLU MET LYS THR TYR SER SEQRES 46 A 709 VAL SER PHE ASP SER LEU PHE SER ALA VAL LYS ASN PHE SEQRES 47 A 709 THR GLU ILE ALA SER LYS PHE SER GLU ARG LEU GLN ASP SEQRES 48 A 709 PHE ASP LYS SER ASN PRO ILE VAL LEU ARG MET MET ASN SEQRES 49 A 709 ASP GLN LEU MET PHE LEU GLU ARG ALA PHE ILE ASP PRO SEQRES 50 A 709 LEU GLY LEU PRO ASP ARG PRO PHE TYR ARG HIS VAL ILE SEQRES 51 A 709 TYR ALA PRO SER SER HIS ASN LYS TYR ALA GLY GLU SER SEQRES 52 A 709 PHE PRO GLY ILE TYR ASP ALA LEU PHE ASP ILE GLU SER SEQRES 53 A 709 LYS VAL ASP PRO SER LYS ALA TRP GLY GLU VAL LYS ARG SEQRES 54 A 709 GLN ILE TYR VAL ALA ALA PHE THR VAL GLN ALA ALA ALA SEQRES 55 A 709 GLU THR LEU SER GLU VAL ALA MODRES 2PVV ASN A 121 ASN GLYCOSYLATION SITE MODRES 2PVV ASN A 195 ASN GLYCOSYLATION SITE MODRES 2PVV ASN A 459 ASN GLYCOSYLATION SITE MODRES 2PVV ASN A 76 ASN GLYCOSYLATION SITE MODRES 2PVV ASN A 140 ASN GLYCOSYLATION SITE MODRES 2PVV ASN A 476 ASN GLYCOSYLATION SITE MODRES 2PVV ASN A 638 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET MAN E 3 11 HET MAN E 4 11 HET NAG A1757 14 HET NAG A1759 14 HET NAG A1760 14 HET ZN A1751 1 HET ZN A1752 1 HET CA A1753 1 HET CL A1754 1 HET OSE A1768 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM CL CHLORIDE ION HETNAM OSE O-SULFO-L-SERINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 11(C8 H15 N O6) FORMUL 5 MAN 2(C6 H12 O6) FORMUL 9 ZN 2(ZN 2+) FORMUL 11 CA CA 2+ FORMUL 12 CL CL 1- FORMUL 13 OSE C3 H7 N O6 S FORMUL 14 HOH *510(H2 O) HELIX 1 1 ASN A 57 LEU A 65 1 9 HELIX 2 2 LYS A 66 THR A 78 1 13 HELIX 3 3 THR A 86 PHE A 103 1 18 HELIX 4 4 ARG A 181 ASP A 191 1 11 HELIX 5 5 PHE A 209 ALA A 220 1 12 HELIX 6 6 ASP A 230 PHE A 235 1 6 HELIX 7 7 GLY A 282 ALA A 286 5 5 HELIX 8 8 GLY A 298 GLU A 307 1 10 HELIX 9 9 ASP A 316 ARG A 320 5 5 HELIX 10 10 THR A 334 SER A 338 5 5 HELIX 11 11 PRO A 388 GLU A 408 1 21 HELIX 12 12 ALA A 423 GLY A 427 5 5 HELIX 13 13 LEU A 428 ASN A 438 1 11 HELIX 14 14 ASN A 438 ARG A 445 1 8 HELIX 15 15 MET A 470 GLU A 480 1 11 HELIX 16 16 SER A 492 SER A 501 1 10 HELIX 17 17 PHE A 521 ARG A 527 1 7 HELIX 18 18 TRP A 541 LYS A 545 5 5 HELIX 19 19 THR A 558 TYR A 566 1 9 HELIX 20 20 PHE A 570 SER A 590 1 21 HELIX 21 21 ASP A 596 MET A 616 1 21 HELIX 22 22 HIS A 618 TYR A 625 1 8 HELIX 23 23 PHE A 629 ASP A 652 1 24 HELIX 24 24 ASN A 657 PHE A 675 1 19 HELIX 25 25 PHE A 705 PHE A 713 1 9 HELIX 26 26 ASP A 714 LYS A 718 5 5 HELIX 27 27 ASP A 720 THR A 745 1 26 SHEET 1 A 7 SER A 107 TYR A 119 0 SHEET 2 A 7 THR A 349 LEU A 362 -1 O ASN A 357 N ALA A 111 SHEET 3 A 7 ARG A 414 TRP A 421 -1 O PHE A 418 N GLY A 360 SHEET 4 A 7 GLU A 367 HIS A 377 1 N VAL A 372 O LEU A 417 SHEET 5 A 7 GLY A 446 ASN A 451 1 O ILE A 450 N ILE A 373 SHEET 6 A 7 ALA A 531 THR A 538 1 O ALA A 531 N TYR A 449 SHEET 7 A 7 THR A 461 CYS A 466 -1 N THR A 461 O THR A 538 SHEET 1 B 4 GLU A 137 ASN A 140 0 SHEET 2 B 4 TYR A 127 ILE A 131 -1 N ILE A 130 O ILE A 138 SHEET 3 B 4 LYS A 341 HIS A 345 -1 O LYS A 343 N SER A 129 SHEET 4 B 4 GLU A 171 GLY A 172 -1 N GLY A 172 O VAL A 342 SHEET 1 C 4 LEU A 174 TYR A 176 0 SHEET 2 C 4 ILE A 200 ARG A 204 1 O ILE A 202 N VAL A 175 SHEET 3 C 4 GLY A 224 TYR A 228 1 O ILE A 226 N ALA A 203 SHEET 4 C 4 VAL A 294 ILE A 297 1 O ILE A 297 N LEU A 227 SHEET 1 D 2 TYR A 692 SER A 695 0 SHEET 2 D 2 ASN A 698 SER A 704 -1 O ALA A 701 N SER A 695 LINK ND2 ASN A 76 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 121 C1 NAG A1757 1555 1555 1.44 LINK ND2 ASN A 140 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 195 C1 NAG A1759 1555 1555 1.44 LINK ND2 ASN A 459 C1 NAG A1760 1555 1555 1.46 LINK ND2 ASN A 476 C1 NAG D 1 1555 1555 1.46 LINK ND2 ASN A 638 C1 NAG E 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.43 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.43 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O4 NAG E 2 C1 MAN E 3 1555 1555 1.43 LINK O3 MAN E 3 C1 MAN E 4 1555 1555 1.45 LINK O THR A 269 CA CA A1753 1555 1555 2.41 LINK OG1 THR A 269 CA CA A1753 1555 1555 2.53 LINK O TYR A 272 CA CA A1753 1555 1555 2.28 LINK NE2 HIS A 377 ZN ZN A1752 1555 1555 1.97 LINK OD2 ASP A 387 ZN ZN A1751 1555 1555 2.01 LINK OD1 ASP A 387 ZN ZN A1752 1555 1555 2.11 LINK OE1 GLU A 425 ZN ZN A1751 1555 1555 2.40 LINK OE2 GLU A 425 ZN ZN A1751 1555 1555 1.96 LINK OE1 GLU A 433 CA CA A1753 1555 1555 2.43 LINK OE2 GLU A 433 CA CA A1753 1555 1555 2.49 LINK OE2 GLU A 436 CA CA A1753 1555 1555 2.36 LINK OD2 ASP A 453 ZN ZN A1752 1555 1555 2.04 LINK OD1 ASP A 453 ZN ZN A1752 1555 1555 2.70 LINK NE2 HIS A 553 ZN ZN A1751 1555 1555 2.11 LINK ZN ZN A1751 O HOH A2263 1555 1555 2.16 LINK ZN ZN A1752 O HOH A2263 1555 1555 1.82 LINK CA CA A1753 O HOH A1774 1555 1555 2.45 CISPEP 1 TYR A 242 PRO A 243 0 4.12 CISPEP 2 GLY A 330 PRO A 331 0 1.34 CISPEP 3 ASP A 387 PRO A 388 0 4.19 CRYST1 101.617 130.220 158.975 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009841 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007679 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006290 0.00000